Synchronicity Pharma Highlights New Research Demonstrating Beneficial Effects of Modulating Core Clock Proteins in Glioblastoma Stem Cells
27 août 2019 09h00 HE
|
Synchronicity Pharma
SAN FRANCISCO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Synchronicity Pharma (“Synchronicity”), a clinical-stage company focused on therapeutic translation of circadian clock biology, today announced the...